Wiyuan Synthesis Closes Series A to Fuse AI with Synthetic Biology Round: Series A — 43,354,800 CNY (≈$6.07 million) Announced: 30 March 2026 Sector: AI, Biotech --- ### What This Round Signals A Series A of 43,354,800 CNY (≈$6.07 million) is not a headline-grabbing number by global standards. But the story Wiyuan Synthesis is telling with this raise is worth paying close attention to — not because of the size, but because of the category it plants a flag in. The company sits at the intersection of AI-driven biological computing and synthetic biology, and it is building what it describes as an open collaboration platform for AI biological computing applications. That framing — open, collaborative, infrastructure-level — is a deliberate positioning move, and it reflects a broader pattern emerging from China's life sciences ecosystem: the ambition to own the tooling layer of the next generation of biological research, not…